PATENT CLAIM ANALYSIS

Application Number: 15742265
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-07
Patent Classification: ["424", "186100"]

Abstract:
Stable pre-fusion respiratory syncitial virus (RSV) F polypeptides, immunogenic compositions including the polypeptides, and uses thereof for the prevention and/or treatment of RSV infection are described.

Claim (Index 7):
The pre-fusion RSV F polypeptide according to  claim 5 , wherein the trimerization domain is linked to amino acid residue 513 of the RSV F protein.

Metadata:
- Claim Count in Document: 29.0
- Percentile: 86.0
- Lexical Diversity: 1.14815
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14899531', '15742249', '15385611', '14776651', '14340519']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7747578137985044
- 35 USC 102 Novelty (BERT): 0.5509663759998182
- Combined Prediction Score: 0.7523786700186358
- Mean Citation Score: 366.02737
- Max Citation Score: 433.5047
- Similarity Product: 288.4334201801658

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test